Please use this identifier to cite or link to this item:
https://accedacris.ulpgc.es/handle/10553/52006
| Title: | Interleukin-1 antagonism in type 1 diabetes of recent onset: Two multicenter, randomized double-masked, placebo-controlled trials | Authors: | Moran, A. Bundy, B. Becker, D. J. DiMeglio, L. A. Gitelman, S. E. Goland, R. Greenbaum, C. J. Herold, K. C. Marks, J. B. Raskin, P. Sanda, S. Schatz, D. Wherrett, D. Wilson, D. M. Krischer, J. P. Skyler, J. S. Pickersgill, L. De Koning, E. Ziegler, A. G. Böehm, B. Badenhoop, K. Schloot, N. Bak, J. F. Pozzilli, P. Mauricio, D. Donath, M. Y. Castaño, L. Wägner, A. Lervang, H. H. Perrild, H. Mandrup-Poulsen, T. |
UNESCO Clasification: | 32 Ciencias médicas 320502 Endocrinología |
Keywords: | Interleukin-1 Diabetes Trials |
Issue Date: | 2014 | Journal: | Diabetes Technology and Therapeutics | URI: | https://accedacris.ulpgc.es/handle/10553/52006 | ISSN: | 1520-9156 | DOI: | 10.1089/dia.2014.1510 | Source: | Diabetes Technology and Therapeutics[ISSN 1520-9156],v. 16 |
| Appears in Collections: | Comentario |
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.